Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Glioma"" wg kryterium: Temat


Tytuł:
Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.
Autorzy:
Chatterjee J; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Sanapala S; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Cobb O; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Bewley A; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Goldstein AK; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Cordell E; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Ge X; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Garbow JR; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Holtzman MJ; Department of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2021 Dec 08; Vol. 12 (1), pp. 7122. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Glioma*
Asthma/*immunology
Asthma/*metabolism
Decorin/*metabolism
Microglia/*metabolism
T-Lymphocytes/*immunology
Animals ; Brain Neoplasms/pathology ; Chemokine CCL4/metabolism ; Chemokine CCL5/metabolism ; Disease Models, Animal ; Mice ; Mice, Inbred C57BL ; Monitoring, Immunologic ; Neurofibromatosis 1/metabolism ; Neurofibromin 1/genetics ; Neurofibromin 1/metabolism ; Optic Nerve/metabolism ; Optic Nerve Glioma/pathology ; Signal Transduction
Czasopismo naukowe
Tytuł:
A Case of Cerebellar Intraparenchymal Subependymoma with Next-Generation Sequencing Analysis.
Autorzy:
Kwon HJ; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea.; Department of Pathology, 35032Yeungnam University College of Medicine, Daegu, Republic of Korea.
Kim SH; Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Suh YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Feb; Vol. 31 (1), pp. 69-75. Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Glioma, Subependymal*/diagnosis
Glioma, Subependymal*/genetics
Glioma, Subependymal*/surgery
Glioma*/pathology
Female ; Humans ; Middle Aged ; Spinal Cord/pathology ; Cerebellum/pathology ; Magnetic Resonance Imaging ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
Predictors of seizure outcomes in patients with diffuse low-grade glioma-related epilepsy after complete glioma removal.
Autorzy:
He X; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Zhang K; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Liu D; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Yang Z; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Yang Z; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Feb; Vol. 29 (2), pp. 736-743. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/complications
Brain Neoplasms*/surgery
Brain Neoplasms*/pathology
Glioma*/complications
Glioma*/surgery
Glioma*/pathology
Epilepsy*/etiology
Epilepsy*/surgery
Epilepsy*/pathology
Humans ; Retrospective Studies ; Treatment Outcome ; Seizures/epidemiology ; Seizures/etiology ; Seizures/surgery
Czasopismo naukowe
Tytuł:
Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Autorzy:
Mueller T; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Laternser S; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Guerreiro Stücklin AS; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Gerber NU; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Mourabit S; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Rizo M; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Rushing EJ; Division of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
Kottke R; Department of Diagnostic Imaging, University Children's Hospital Zurich, Zurich, Switzerland.
Grotzer M; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Krayenbühl N; Department of Neurosurgery, University Children's Hospital Zurich, Zurich, Switzerland.
Nazarian J; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; Children's National Health System, Center for Genetic Medicine Research, Washington, DC, 20010, USA.
Mueller S; Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; Department Neurology, Neurosurgery, and Pediatrics, University of California San Francisco, San Francisco, CA, 94158, USA. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jan; Vol. 178, pp. 171-179. Date of Electronic Publication: 2022 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Stem Neoplasms*/drug therapy
Brain Stem Neoplasms*/genetics
Glioma*/drug therapy
Glioma*/genetics
Glioma*/pathology
Child ; Humans ; Mutation ; Clinical Decision-Making
Czasopismo naukowe
Tytuł:
Survival analysis in high-grade glioma: The role of salvage surgery.
Autorzy:
Vargas López AJ; Servicio de Neurocirugía, Hospital Universitario Torrecárdenas, Almería, Spain; Programa de Doctorado en Medicina y Cirugía, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: .
Fernández Carballal C; Servicio de Neurocirugía, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Valera Melé M; Servicio de Neurocirugía, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Rodríguez-Boto G; Programa de Doctorado en Medicina y Cirugía, Universidad Autónoma de Madrid, Madrid, Spain; Servicio de Neurocirugía, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Pokaż więcej
Źródło:
Neurologia [Neurologia (Engl Ed)] 2023 Jan-Feb; Vol. 38 (1), pp. 21-28. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnosis
Glioma*/surgery
Glioma*/diagnosis
Glioma*/pathology
Humans ; Middle Aged ; Retrospective Studies ; Survival Analysis ; Spain
Czasopismo naukowe
Tytuł:
Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study.
Autorzy:
Kim HJ; Department of Radiation Oncology, Gachon University Gil Hospital, Incheon, Korea.
Lee JH; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University, College of Medicine, Seoul, Korea.
Kim Y; Department of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Korea.
Lim DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park SH; Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu, Korea.
Ahn SD; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim IA; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.
Im JH; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Chung JW; Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.
Kim JY; Proton Therapy Center, National Cancer Center, Goyang, Korea.
Kim IH; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University, College of Medicine, Seoul, Korea.
Yoon HI; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Suh CO; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jan; Vol. 55 (1), pp. 41-49. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Diffuse Intrinsic Pontine Glioma*
Brain Stem Neoplasms*/diagnosis
Brain Stem Neoplasms*/radiotherapy
Brain Stem Neoplasms*/pathology
Glioma*/pathology
Child ; Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Bone marrow-derived mesenchymal stem cells expressing BMP2 suppress glioma stem cell growth and stemness through Bcl-2/Bax signaling.
Autorzy:
Feng J; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yao Z; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yang H; Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Ma J; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhong X; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Qin Y; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Li J; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Dec; Vol. 18 (7), pp. 2033-2040.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cells*/metabolism
Glioma*/therapy
Glioma*/drug therapy
Humans ; bcl-2-Associated X Protein/genetics ; bcl-2-Associated X Protein/metabolism ; Bone Marrow/metabolism ; Cell Proliferation/genetics ; Neoplastic Stem Cells/metabolism ; Bone Morphogenetic Protein 2/genetics ; Bone Morphogenetic Protein 2/metabolism ; Bone Morphogenetic Protein 2/pharmacology
Czasopismo naukowe
Tytuł:
The effect of hypoxia on photodynamic therapy with 5-aminolevulinic acid in malignant gliomas.
Autorzy:
Ihata T; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan.
Nonoguchi N; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan. Electronic address: .
Fujishiro T; Department of Neurosurgery, Tanabe Neurosurgical Hospital, Fujiidera, Osaka, Japan.
Omura N; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan.
Kawabata S; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan.
Kajimoto Y; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan.
Wanibuchi M; Department of Neurosurgery and Endovascular Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka 569-8686, Japan.
Pokaż więcej
Źródło:
Photodiagnosis and photodynamic therapy [Photodiagnosis Photodyn Ther] 2022 Dec; Vol. 40, pp. 103056. Date of Electronic Publication: 2022 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Photochemotherapy*/methods
Glioma*/drug therapy
Glioma*/pathology
Humans ; Aminolevulinic Acid/pharmacology ; Aminolevulinic Acid/therapeutic use ; Aminolevulinic Acid/metabolism ; Protoporphyrins/metabolism ; Cell Line, Tumor ; Hypoxia/drug therapy ; Oxygen ; Photosensitizing Agents/pharmacology ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Propofol Suppresses Glioma Tumorigenesis by Regulating circ_0047688/miR-516b-5p/IFI30 Axis.
Autorzy:
Li Y; Department of Anesthesiology, Yantaishan Hospital, Yantai, China.
Liu Y; Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China.
Zhang J; Department of Anesthesiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210002, China.
Li J; Department of Anesthesiology, Yantaishan Hospital, Yantai, China.
Shu Y; Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China. .
Pokaż więcej
Źródło:
Biochemical genetics [Biochem Genet] 2023 Feb; Vol. 61 (1), pp. 151-169. Date of Electronic Publication: 2022 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Propofol*/pharmacology
Glioma*/drug therapy
Glioma*/genetics
MicroRNAs*/genetics
Humans ; Animals ; Mice ; Carcinogenesis ; Apoptosis ; Cell Proliferation ; Disease Models, Animal ; Oxidoreductases Acting on Sulfur Group Donors
Czasopismo naukowe
Tytuł:
Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markers.
Autorzy:
Haldar D; Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kazerooni AF; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Arif S; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Familiar A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Madhogarhia R; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Khalili N; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bagheri S; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anderson H; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Shaikh IS; Department of Medicine, Crozer-Chester Medical Center, Chester, Pennsylvania, USA.
Mahtabfar A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Neurological Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Kim MC; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Tu W; College of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ware J; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Vossough A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Davatzikos C; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Storm PB; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Division of Neurological Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Resnick A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Nabavizadeh A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Radiology, Hospital of University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: .
Pokaż więcej
Źródło:
Neoplasia (New York, N.Y.) [Neoplasia] 2023 Feb; Vol. 36, pp. 100869. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/diagnostic imaging
Glioma*/genetics
Glioma*/metabolism
Humans ; Child ; Unsupervised Machine Learning ; Proto-Oncogene Proteins B-raf ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Biomarkers
Czasopismo naukowe
Tytuł:
Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Autorzy:
Hong X; Medical School of Jingchu University of Technology, Jingmen 448000, China.
Zhang J; The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China.
Zou J; The Seventh Affiliated Hospital of Southern Medical University, Foshan 528244, China.
Ouyang J; The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China.
Xiao B; The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China.
Wang P; The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China. Electronic address: .
Peng X; The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China. Electronic address: .
Pokaż więcej
Źródło:
Cellular signalling [Cell Signal] 2023 Feb; Vol. 102, pp. 110560. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Glioma*/drug therapy
Glioma*/genetics
Glioma*/metabolism
Humans ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Apoptosis ; RNA, Messenger ; Cell Line, Tumor ; Tumor Microenvironment ; Collagen Type VI/pharmacology
Czasopismo naukowe
Tytuł:
Multicenter clinical radiomics-integrated model based on [ F]FDG PET and multi-modal MRI predict ATRX mutation status in IDH-mutant lower-grade gliomas.
Autorzy:
Zhang L; Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Pan H; College of Computer & Information Science, Southwest University, Chongqing, 400715, China.
Liu Z; Department of Radiology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400021, China.
Gao J; Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xu X; Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wang L; Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wang J; Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Tang Y; Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, Chongqing, China.
Cao X; School of Medical and Life Sciences Chengdu University of Traditional Chinese Medicine, Chengdu, 610032, China.
Kan Y; Department of Nuclear Medicine, United Medical Imaging Center, Chongqing, 400038, China.
Wen Z; Department of Radiology, Sichuan Cancer Hospital, Chengdu, 610042, China.
Chen J; Department of Nuclear Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Huang D; Department of Nuclear Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China. .
Chen S; College of Computer & Information Science, Southwest University, Chongqing, 400715, China. .
Li Y; Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Feb; Vol. 33 (2), pp. 872-883. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Intellectual Disability*
alpha-Thalassemia*
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Glioma*/diagnostic imaging
Glioma*/genetics
Glioma*/metabolism
Humans ; Fluorodeoxyglucose F18 ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Mutation ; X-linked Nuclear Protein/genetics
Czasopismo naukowe
Tytuł:
Xanthatin suppresses proliferation and tumorigenicity of glioma cells through autophagy inhibition via activation of the PI3K-Akt-mTOR pathway.
Autorzy:
Chen H; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Zhu T; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Huang X; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Xu W; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Di Z; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Ma Y; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Xue M; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Bi S; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shen Y; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Yu Y; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shen Y; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Feng L; School of Basic Medical Sciences, Anhui Medical University, Hefei, China.; Institute of Biopharmaceuticals, Anhui Medical University, Hefei, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Feb; Vol. 11 (1), pp. e01041.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Glioma*/drug therapy
Glioma*/metabolism
Glioma*/pathology
Humans ; Phosphatidylinositol 3-Kinases/metabolism ; Cell Line, Tumor ; TOR Serine-Threonine Kinases/metabolism ; Autophagy
Czasopismo naukowe
Tytuł:
Update on the current knowledge of lymphatic drainage system and its emerging roles in glioma management.
Autorzy:
Lan YL; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Wang H; Department of Neurology, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Chen A; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Zhang J; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Immunology [Immunology] 2023 Feb; Vol. 168 (2), pp. 233-247. Date of Electronic Publication: 2022 Jul 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphatic Vessels*/physiology
Glioma*/therapy
Glioma*/pathology
Humans ; Lymphatic System/pathology ; Lymphatic System/physiology ; Brain ; Meninges
Czasopismo naukowe
Tytuł:
TSPO PET signal using [ F]GE180 is associated with survival in recurrent gliomas.
Autorzy:
Quach S; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Holzgreve A; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Kaiser L; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Dekorsy FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Nelwan DV; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Bartos LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Kirchleitner SV; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Weller J; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Weidner L; Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ruf VC; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
Herms J; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
Stöcklein S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Wetzel C; Department of Psychiatry and Psychotherapy, Molecular Neurosciences, University of Regensburg, Regensburg, Germany.
Riemenschneider MJ; Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
V Baumgarten L; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thon N; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Rupprecht R; Department of Psychiatry and Psychotherapy, Molecular Neurosciences, University of Regensburg, Regensburg, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tonn JC; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Feb; Vol. 50 (3), pp. 859-869. Date of Electronic Publication: 2022 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/therapy
Glioma*/diagnostic imaging
Glioma*/genetics
Glioma*/therapy
Glioblastoma*
Humans ; Neoplasm Recurrence, Local/diagnostic imaging ; Positron-Emission Tomography/methods ; Tyrosine ; Receptors, GABA/genetics ; Receptors, GABA/metabolism
Czasopismo naukowe
Tytuł:
Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and F-FDG-PET.
Autorzy:
Ikeda S; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Sakata A; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: .
Fushimi Y; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Okuchi S; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Arakawa Y; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Makino Y; Department of Neurosurgery, National Hospital Organization Kyoto Medical Center, 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, Japan.
Mineharu Y; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Nakajima S; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Hinoda T; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Yoshida K; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Miyamoto S; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Nakamoto Y; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2023 Feb; Vol. 159, pp. 110658. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Astrocytoma*/diagnostic imaging
Astrocytoma*/genetics
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/diagnostic imaging
Glioma*/genetics
Glioma*/pathology
Telomerase*/genetics
Humans ; Fluorodeoxyglucose F18 ; Isocitrate Dehydrogenase/genetics ; Mutation ; Perfusion ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.
Autorzy:
Bader JM; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Deigendesch N; Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Misch M; Department of Neurosurgery, Charité, Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353 Berlin, Germany.
Mann M; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Koch A; Department of Neuropathology, Charité, Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353 Berlin, Germany. Electronic address: .
Meissner F; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; Department of Systems Immunology and Proteomics, Institute of Innate Immunity, University Hospital Bonn, 53127 Bonn, Germany. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100877. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/genetics
Glioma*/genetics
Glioma*/pathology
Adult ; Humans ; Mutation ; Proteome/genetics ; Proteomics ; Chromosomes, Human, Pair 1 ; Chromosomes, Human, Pair 19
Czasopismo naukowe
Tytuł:
Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Autorzy:
Li Y; PET-CT Center, Chenzhou First People's Hospital, Chenzhou, Hunan, China.; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Feng Y; PET-CT Center, Chenzhou First People's Hospital, Chenzhou, Hunan, China.
Luo F; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peng G; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Li Y; Department of Obstetrics and Gynecology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Jan 16; Vol. 13, pp. 1089792. Date of Electronic Publication: 2023 Jan 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Glioma*/genetics
Glioma*/therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/therapy
Humans ; T-Lymphocytes ; Prognosis ; Cell Proliferation ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion.
Autorzy:
Métais A; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Tauziède-Espariat A; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Garcia J; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Appay R; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.
Meyronet D; Groupe Hospitalier Est, Département de Neuropathologie, Hospices Civils de Lyon, Bron, France.; Claude Bernard University Lyon 1, Lyon, France.; Department of Cancer cell plasticity - INSERM U1052, Cancer Research Center of Lyon, Lyon, France.
Maurage CA; Department of Pathology, Lille University Hospital, Lille, France.
Vandenbos F; Department of Neuropathology, Hôpital Pasteur, Nice, France.
Rigau V; Department of Pathology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Chiforeanu DC; Service d'Anatomie et Cytologie Pathologiques, Pontchaillou University Hospital, Rennes, France.
Pallud J; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.; Department of Neurosurgery, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Senova S; Departments of Neurosurgery and Psychiatry, Assistance Publique-Hôpitaux de Paris (APHP) Groupe Henri-Mondor Albert-Chenevier, Créteil, France.
Saffroy R; Department of Biochemistry and Oncogenetic, APHP, Paul-Brousse Hospital, Villejuif, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Edjlali M; Department of Radiology, APHP, Hôpitaux Raymond-Poincaré and Ambroise Paré, DMU Smart Imaging, U 1179 UVSQ/Paris-Saclay, GH Université Paris-Saclay, Paris, France.; Laboratoire d'imagerie Biomédicale Multimodale (BioMaps), CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Université Paris-Saclay, Orsay, France.
Varlet P; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France. .; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France. .
Pokaż więcej
Corporate Authors:
Biopathology RENOCLIP-LOC network
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Jan 16; Vol. 11 (1), pp. 14. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glioblastoma*/genetics
Glioma*/genetics
Glioma*/pathology
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Ganglioglioma*/genetics
Adult ; Humans ; Child ; Mutation/genetics ; Prognosis ; Epigenesis, Genetic ; DNA ; Isocitrate Dehydrogenase/genetics ; Receptor, Fibroblast Growth Factor, Type 3/genetics ; Microtubule-Associated Proteins/genetics
Czasopismo naukowe
Tytuł:
Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG).
Autorzy:
Liu H; Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Wang J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
Luo T; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
Zhen Z; Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Liu L; Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Third Military Medical University (Army Medical University), Chongqing, China.
Zheng Y; Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Zhang C; Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Hu X; Department of Nuclear Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jan 13; Vol. 13, pp. 1106120. Date of Electronic Publication: 2023 Jan 13 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Glioma*/diagnosis
Glioma*/genetics
CD18 Antigens*/genetics
Humans ; Integrins/genetics ; Methylation ; Prognosis ; Reproducibility of Results
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz